Louisiana enacted Act No. 121 (HB 15, 2025) adding N-Desethyl isotonitazene, etonitazepine, and ethylphenidate to Schedule I

Louisiana enacted Act No. 121 (HB 15, 2025), amending the Uniform Controlled Dangerous Substances Law (UCDSL) to add new substances to Schedule I (R.S. 40:964). The act adds N-Desethyl isotonitazene and etonitazepine as Schedule I opiates, and ethylphenidate as a Schedule I stimulant, and directs the Louisiana State Law Institute to renumber/alphabetize schedule entries. Compliance teams (e.g., healthcare/pharmacy, law enforcement, forensic labs, institutions with controlled-substance controls) should update controlled substance screening lists, handling/procurement controls, and any internal policies tied to Schedule I status.